Concepedia

Mujtaba Khan

MK

Statistics

Publications

15

Citations

323

H-Index

12

Active since

1970

Affiliations

Intas Pharmaceuticals (India)(Current)

Armed Forces Medical College

Command Hospital

Lambda Therapeutic Research (India)

Command Hospital Air Force

Mujtaba Khan is an author at Intas Pharmaceuticals (India) specializing in medicine, oncology, and dermatology.

ORCID

Top concepts

Publications per year

1970–2023

15

Publications

15

Real-Life Clinical Effectiveness of Razumab® (the World’s First Biosimilar of Ranibizumab) in Retinal Vein Occlusion: A Subgroup Analysis of the Pooled Retrospective RE-ENACT Study

Shashikant Sharma, Mujtaba Khan, Alok Chaturvedi · Ophthalmologica · 2018 · 52 citations · Full text

Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder

Ateeq Ahmad, Saifuddin Sheikh, Mujtaba Khan et al. · Bipolar Disorders · 2020 · 38 citations

A Multicenter, Retrospective Study (RE-ENACT 2) on the Use of Razumab™ (World’s First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration

Shashikant Sharma, Mujtaba Khan, Alok Chaturvedi · Ophthalmology and Therapy · 2019 · 35 citations · Full text

Median dermoid cysts of the nose familial occurrence

Mujtaba Khan, A. G. Gibb · The Journal of Laryngology & Otology · 1970 · 30 citations

, , +7

Doceaqualip in a patient with prostate cancer who had an allergic reaction to conventional docetaxel: A case report

Radheshyam Naik, Mujtaba Khan · Molecular and Clinical Oncology · 2017 · 22 citations · Full text

, , +13

1–5 of 15